Fagron, the leading global player in pharmaceutical compounding, announces the successful completion of its acquisition of Vepakum in Latin America. The transaction, announced in December 2025, was ...
Rapid results for ADHD, Anxiety and OCD: Improves executive function and lessens the din of unwelcome thoughts. Calms the overactive amygdala to assist patients in processing trauma free of physical ...
SNIPR also provided a clinical update on its ongoing Phase 1b trial of SNIPR001 in patients with hematological cancer undergoing hematopoietic stem-cell transplantation (HSCT). Recruitment in this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results